MedTrace Logo

Health Promotion Intervention Program at the Workplace

NCT01628419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2015-12-09

No results posted yet for this study

Summary

The purpose of the current investigation is to examine the effects of health intervention program at the workplace on health risks for cardiovascular disease, well-being and absenteeism at the workplace.

Participants: 1500 male and female employees from 10 different companies across Israel will take part in the study. Age: older than 18 yrs.

Hypothesis 1: The intervention program will have positive effects on the health risks for cardiovascular disease. For example: Will be reflected in a decrease in LDL and increase in HDL.

Hypothesis 2: The intervention program will have positive effects on the absenteeism at the workplace (e.g. decrease in days of sick leave per employee).

Conditions

  • Conditions Influencing Health Status

Interventions

BEHAVIORAL

Health intervention

physical activity program at the workplace - once a week with a certified trainer. (The program will include: aerobic exercises as well as resistance exercises). The employees will encourage to perform two additional workouts during the week. Nutritional counseling for the kitchen staff Lectures - lectures will be given at each worksite on different topics: physical activity, nutrition, sleeping behaviour, mental aspects.

Sponsors & Collaborators

  • Wingate Institute

    lead OTHER

Principal Investigators

  • Eyal Shargal, PhD · Wingate Institute, Israel

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01628419 on ClinicalTrials.gov